SOAT1 and acute myeloid leukemia: Ligand binding to the FLT3 receptor initiates a signaling cascade that results in the differential activation of RAS/RAF/MAPK, PI3 kinase, and/or STAT pathways in AML [19], [20], [21], [22], [23], [24], [25], [26].